1. Fauroux B, Clement A, Tournier G. Pulmonary toxicity of drugs and thoracic irradiation in children // Rev Mal Respir. - 1996 Jul. - N. 13(3). - 235-42
2. Leff A. R. Pulmonary and critical care pharmacology and therapeutics. - 1996. - P. 695-723.
3. Music E, Tomsic M, Logar D. Gold salt alveolitis in 3 patients with rheumatoid arthritis // Pneumologie. - 1995 Jun. - N. 49(6). - P. 367-72.
4. Camus P, Foucher P, Bonniaud P, Ask K. Drug-induced infiltrativelung disease // Eur Respir J. - 2001. - N. 32. - 93S-100S.
5. Imokawa S., Colby T.V., Leslie K.O., Helmers R.A.Methotrexate pneumonitis: review of the literature and histopathological findings in nine patients // Eur Respir J. - 2000 Feb. - 15(2). - 373-81.
6. Nemery B., Bast A., Behr J., Borm P.J., Bourke S.J., Camus P.H., De Vuyst P., Jansen H.M., Kinnula V.L., Lison D., Pelkonen O., Saltini C. Interstitial lung disease induced by exogenous agents: factors governing susceptibility // Eur Respir J Suppl. - 2001 Sep. - 32. - 30s-42s.
7. Vaszar L.T., Stevenson D.D. Aspirin-induced asthma // Clin Rev Allergy Immunol. - 2001. - 21. - 71-87.
8. Schneider R.K., Levenson J.L., Schnoll S.H. Update in addiction medicine // Ann Intern Med 2001. - 134. - 387-95.
9. Simonneau G., Galie N., Rubin L.J., et al. Clinical classification of pulmonary hypertension // J Am Coll Cardiol. - 2004. - 43. - Suppl S. - 5S-12S.
10. MacNee W. Major Symposium: Smoking-induced lung injury. Mechanisms of cigarette smoke-induced lung inflammation: pro-inflammatory and protective mechanisms. Program and abstracts of the 12th European Respiratory Society Annual Congress; September 14-18, 2002. - Stockholm, Sweden. - 2002.
11. Albertson T.E., Walby W.F. Respiratory toxicities from stimulant use // Clin Rev Allergy Immunol. - 1997. - 15. - 221-41.